空
空
空
空
空
Star product
Biological counterterrorism reagents, reference materials, and quality control products
The company operates six major technology platforms, with a product portfolio spanning clinical molecular diagnostics, clinical immunoassays, clinical blood typing, reference materials and quality control, custom research‑grade products, and hospital‑acquired infection control.
-
Clinical Molecular DiagnosticsJinhao Pharmaceutical offers molecular diagnostic reagents (fluorescent PCR), real-time fluorescent PCR instruments, nucleic acid extraction systems, and associated reagents, along with customized product development services. Its products are primarily used for pathogen detection in infectious diseases and for nucleic acid extraction.查看详情
-
Clinical ImmunodiagnosisImmunoassays are based on the specific antigen–antibody binding reaction to detect target analytes in samples and are widely used in clinical diagnostics. Jinhao Pharmaceutical offers a range of immunoassay products, including rapid biosafety tests and infectious disease assays…查看详情
-
Clinical Blood Group IdentificationJinhao Pharmaceutical offers blood-typing and transfusion‑compatibility reagents and quality‑control products, ensuring the safety of clinical blood transfusions.查看详情
-
Reference Materials and Quality ControlJinhao Pharmaceutical offers 84 certified reference materials that have been granted national Level II standard substance certification, covering major blood‑screening assays. Customers can select the appropriate concentration based on different brands and methodologies, with both liquid and lyophilized formulations available.查看详情
Jinhao Pharmaceutical operates the Thethirdqc Quality Control Cloud Service Platform, offering users and quality‑control‑responsible institutions a suite of functional modules, including interlaboratory comparisons, blind‑sample assessments, and exchange‑and‑training programs. As an effective pillar of quality control, it continuously enhances the reliability of test results and promotes the healthy development of the industry.
-
Research-Customized ProductsJinhao Pharmaceutical offers customized molecular diagnostics research services, capable of designing and manufacturing molecular diagnostic products exclusively for scientific research, tailored to the specific needs of each client’s project.查看详情
-
Infection ControlMedical multi-enzyme cleaning agents are suitable for pre‑soaking, manual cleaning, ultrasonic cleaning, and mechanical cleaning of clinical instruments and endoscopes after use. The product effectively removes surface contaminants, providing a clean baseline for subsequent disinfection of medical devices and supporting hospital‑acquired infection prevention and control.查看详情
View more
Latest News
News Updates
About Us
Beijing Jinhao Pharmaceutical Co., Ltd. was established in 1993 and specializes in the research, development, operation, and widespread application of immunodiagnostic and molecular diagnostic reagents and associated compact instruments for infectious diseases; blood‑type and transfusion‑compatibility quality control materials; bio‑terrorism countermeasures; certified reference materials; and third‑party quality‑control information platforms. The company provides users with comprehensive testing and monitoring solutions that integrate cutting‑edge diagnostic reagents, advanced instruments, data analysis, and technical services. To date, more than 100 Jinhao products have received national approval and have been deployed across disease prevention and control centers, blood banks, and hospital transfusion departments at all levels nationwide.
Forge ahead and open up cooperation
View more
Contact Us
400-650-6787
Committed to creating greater value for our customers.
Our products are sold nationwide and have earned widespread customer recognition.
Widely used products
Follow us
Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |
© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2